Sandoz Stock
Sandoz Stock price
Key metrics
Is Sandoz a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.
Sandoz Stock Analysis
Analyst Opinions
19 Analysts have issued a Sandoz forecast:
Analyst Opinions
19 Analysts have issued a Sandoz forecast:
Financial data from Sandoz
| Dec '24 |
+/-
%
|
||
| Revenue | 8,334 8,334 |
-
|
|
| Gross Profit | 3,954 3,954 |
-
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 246 246 |
-
|
| Net Profit | - - |
-
|
|
In millions CHF.
Don't miss a Thing! We will send you all news about Sandoz directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Sandoz Stock News
Company Profile
Sandoz Group AG engages in focusing on generic pharmaceuticals and bio similar medical products. It acquires, manages and sells investments and intellectual property in the healthcare and medical device industry and conducts all business at home and abroad. The firm can acquire, sell, debit and manage interests in other companies, intellectual property rights and real estate at home and abroad, as well as establish branches and subsidiaries at home and abroad. The company was founded on January 17, 2022 and is headquartered in Rotkreuz, Switzerland.
| Head office | Switzerland |
| CEO | Mr. Saynor |
| Employees | 22,633 |
| Founded | 2022 |
| Website | www.sandoz.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
